Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07189754 · ClinicalTrials.gov registry record · NA
A Study of Sabroxy™ (Oroxylum Indicum Extract) for Improving Cognitive Function in Adults With Mild Memory Concerns
A NA study, sponsored by SF Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT07189754 is a NA study that has completed, run by SF Research Institute. The registered enrollment target is 70 participants.
The verdict
NCT07189754, a NA study, has completed, sponsored by SF Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This study is testing whether Sabroxy™ (Oroxylum indicum extract) can improve memory and thinking in older adults who report mild problems with their cognition. The study will also measure levels of a protein in the blood called BDNF (Brain-Derived Neurotrophic Factor), which is linked to brain health. The main questions are: Does taking Sabroxy™ improve memory, focus, and overall cognitive performance compared to placebo (a capsule that looks the same but has no active ingredient)? Does Sabroxy™ increase levels of BDNF in the blood? About 80 participants between the ages of 60 and 85 will take part. All participants will be randomly assigned to receive either Sabroxy™ or placebo twice daily for 12 weeks. Neither the participants nor the researchers will know which group they are in (double-blind design). During the study, participants will: Take one capsule twice daily after meals. Complete computerized cognitive tests (COMPASS), interviews with the Montreal Cognitive Assessment (MoCA), and self-assessment questionnaires on memory and thinking. Provide blood samples to measure BDNF. Attend 4 clinic visits (baseline, week 4, week 8, and week 12). Keep a daily diary to track product use and study compliance. The goal is to see whether Sabroxy™ can safely and effectively support cognitive health in older adults with mild memory concerns.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Sabroxy™ (Oroxylum indicum extract)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2020-11-02 |
| Est. Completion | 2021-02-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07189754
The ClinicalTrials.gov registry entry for NCT07189754 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SF Research Institute, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07189754 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07189754 about?
NCT07189754 is a clinical study titled "A Study of Sabroxy™ (Oroxylum Indicum Extract) for Improving Cognitive Function in Adults With Mild Memory Concerns". This study is testing whether Sabroxy™ (Oroxylum indicum extract) can improve memory and thinking in older adults who report mild problems with their cognition. The study will also measure levels of a protein in the blood called BDNF (Brain-Derived Neurotrophic Factor), which is linked to brain heal...
What is the current status of trial NCT07189754?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2020-11-02. Estimated completion is 2021-02-08.
What interventions are being tested in trial NCT07189754?
The interventions under investigation include: Placebo (OTHER), Sabroxy™ (Oroxylum indicum extract) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07189754?
This trial is sponsored by SF Research Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.